» Articles » PMID: 16980116

Burden of Valvular Heart Diseases: a Population-based Study

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2006 Sep 19
PMID 16980116
Citations 1418
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Valvular heart diseases are not usually regarded as a major public-health problem. Our aim was to assess their prevalence and effect on overall survival in the general population.

Methods: We pooled population-based studies to obtain data for 11 911 randomly selected adults from the general population who had been assessed prospectively with echocardiography. We also analysed data from a community study of 16 501 adults who had been assessed by clinically indicated echocardiography.

Findings: In the general population group, moderate or severe valve disease was identified in 615 adults. There was no difference in the frequency of such diseases between men and women (p=0.90). Prevalence increased with age, from 0.7% (95% CI 0.5-1.0) in 18-44 year olds to 13.3% (11.7-15.0) in the 75 years and older group (p<0.0001). The national prevalence of valve disease, corrected for age and sex distribution from the US 2000 population, is 2.5% (2.2-2.7). In the community group, valve disease was diagnosed in 1505 (1.8% adjusted) adults and frequency increased considerably with age, from 0.3% (0.2-0.3) of the 18-44 year olds to 11.7% (11.0-12.5) of those aged 75 years and older, but was diagnosed less often in women than in men (odds ratio 0.90, 0.81-1.01; p=0.07). The adjusted mortality risk ratio associated with valve disease was 1.36 (1.15-1.62; p=0.0005) in the population and 1.75 (1.61-1.90; p<0.0001) in the community.

Interpretation: Moderate or severe valvular diseases are notably common in this population and increase with age. In the community, women are less often diagnosed than are men, which could indicate an important imbalance in view of the associated lower survival. Valve diseases thus represent an important public-health problem.

Citing Articles

Urgent Transcatheter Mitral Edge-to-Edge Repair Is Associated With Worse in-Hospital Outcomes: A Nationwide Analysis.

Diaz-Arocutipa C, Benites-Moya C, Torres-Valencia J, Mehta A, Vicent L Clin Cardiol. 2025; 48(3):e70067.

PMID: 40063420 PMC: 11892689. DOI: 10.1002/clc.70067.


Managing Commissural Mitral Valve Regurgitation Following Transcatheter Mitral Valve Repair Using the Amplatzer Occluder Device.

Zughaib M, Patel H, Assaf A, Saba S, Alexander P Cureus. 2025; 17(2):e78507.

PMID: 40062032 PMC: 11885197. DOI: 10.7759/cureus.78507.


A Case of Successful Treatment of Left Ventricular Rupture after Transcatheter Aortic Valve Implantation.

Tuleutayev R, Abzaliyev K, Kolesnikov A, Kim I, Abzaliyeva S Acta Med Litu. 2025; 31(2):339-350.

PMID: 40060242 PMC: 11887837. DOI: 10.15388/Amed.2024.31.2.3.


Precision medicine in the management of valvular heart disease.

Nettersheim F, Baldus S Herz. 2025; .

PMID: 40035804 DOI: 10.1007/s00059-025-05299-w.


A chronological history of heart valve prostheses to offer perspectives of their limitations.

Evangelista R, Pires A, Nogueira B Front Bioeng Biotechnol. 2025; 13:1533421.

PMID: 40028289 PMC: 11868121. DOI: 10.3389/fbioe.2025.1533421.